Cholangiocarcinoma (CCA) is a heterogeneous group of tumours, derived from cells of the
biliary tree, which represent the second most frequent primary liver tumour. According to the …

Liver cancer represents the third leading cause of cancer-related death worldwide.
Cholangiocarcinoma (CCA) is the second most common type of liver cancer after …

Cholangiocarcinoma, the second most common hepatobiliary malignancy after
hepatocellular carcinoma, is a heterogeneous disease entity with widely varying radiologic …

Biliary tract cancers (BTCs) are rare with poor prognosis. Due to the advent of genomic
sequencing, new data have emerged regarding the molecular makeup of this disease. To …

The effective management of biliary tract cancers (BTCs) has been hampered by limited
options for systemic therapy. In recent years, the focus on precision medicine has made …

Intrahepatic cholangiocarcinomas account for approximately 20% of cases of
cholangiocarcinomas. Three growth patterns or morphologic subtypes exist, including mass …

Simple Summary The noninvasive differentiation of hepatocellular carcinoma (HCC) from
intrahepatic cholangiocarcinoma (ICC) remains challenging. In recent years, the number of …

Cholangiocarcinomas are a heterogeneous group of highly aggressive cancers that may
arise anywhere within the biliary tree. There is a wide geographical variation with regards to …

Cholangiocarcinoma (CCA) is an aggressive and lethal malignancy with limited therapeutic
options. Despite recent advances in diagnostic imaging for CCA, the early diagnosis of CCA …

Tumors of the liver and biliary tree, mainly hepatocellular carcinoma and
cholangiocarcinoma, are the second leading cause of cancer related death worldwide and …